DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» CD33
CD33
Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
AML Serum Mir-150 Mir-155 Mir-1246 Prog
Immunocytochemical Analysis of Human Synovial Lining Cells: Phenotypic Relation to Other Marrow Ann Rheum Dis: First Published As 10.1136/Ard.50.5.311 on 1 May 1991
Human Lectins, Their Carbohydrate Affinities and Where to Find Them
CD33-Specific Chimeric Antigen Receptor T Cells Exhibit Potent Preclinical Activity Against Human Acute Myeloid Leukemia
Multiomics of Azacitidine-Treated AML Cells Reveals Variable And
Prognostic Role of Tetraspanin CD81 in Patients Withacute Myeloid Leukemia
(CD33) Serves As an Immune Checkpoint Receptor for HBV Infection
Supplementary Materials
Engineered Type 1 Regulatory T Cells Designed for Clinical Use Kill Primary
Safety, Tolerability, and Preliminary Activity of IMGN529, a CD37
Tetraspanin CD81 Is an Adverse Prognostic Marker in Acute Myeloid Leukemia
Phenotypic Alteration of Neutrophils in the Blood of HIV Seropositive Patients
Anti-Human CD63 (H5C6)-150Nd
Targeting Cd37 and Folate Receptor for Cancer Therapy: Strategies Based on Engineered Proteins and Liposomes
Mouse CD Marker Chart Bdbiosciences.Com/Cdmarkers
Departments of 3Oncology and 4Pathology, St. Jude
Understanding the Cellular Mechanisms of the Leukocyte Adhesion Deficiency Type Iii Disorder with the Use of Patient Induced Pluripotent Stem Cells
Top View
MDS Conference
Multimarker Analysis Methods for the Rapid Characterization of Pluripotent, Multipotent, and Differentiating Stem Cells
Multiomyx™ Panel Brochure
Bone Marrow Monocytes and Derived Dendritic Cells From
Change the Normal Expose the Cancer
CD9, a Potential Leukemia Stem Cell Marker, Regulates Drug Resistance
REVIEW Characteristics and Analysis of Normal and Leukemic Stem Cells
Cd Marker Antibodies
Monocytes and Macrophages in Flow: an ESCCA Initiative on Advanced Analyses of Monocyte Lineage Using Flow Cytometry
T Cell Engaging Bispecific Antibodies Targeting CD33 Igv and Igc Domains for the Treatment of Acute Myeloid Leukemia
AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate As a Potential Therapeutic for B/T-Cell Malignancies and AML: a New Role for CD37 in AML Daniel S
Two Acute Monocytic Leukemia (AML-M5a) Cell Lines
Immune Checkpoint Blockade and CAR-T Cell Therapy in Hematologic Malignancies Hao Wang1†, Gurbakhash Kaur2†, Alexander I
Development of a Specific System for Targeting Protein to Metallophilic Macrophages
CD Antigen Expression (Myeloid & Lymphoid)
Multiomics of Azacitidine-Treated AML Cells Reveals Variable And
A Guide to Human Immune Cell Characterization by Flow Cytometry Immune Cell Characterization by Flow Cytometry
Microglial Trogocytosis and the Complement System Regulate Axonal Pruning in Vivo Tony KY Lim, Edward S Ruthazer*